Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Larry A. Distiller"'
Autor:
Brian Godman, Debashis Basu, Yogan Pillay, Julius C. Mwita, Godfrey Mutashambara Rwegerera, Bene D. Anand Paramadhas, Celda Tiroyakgosi, Patrick Mbah Okwen, Loveline Lum Niba, Justice Nonvignon, Israel Sefah, Margaret Oluka, Anastasia N. Guantai, Dan Kibuule, Francis Kalemeera, Mwangana Mubita, Joseph Fadare, Olayinka O. Ogunleye, Larry A. Distiller, Enos M. Rampamba, Jeffrey Wing, Debjani Mueller, Abubakr Alfadl, Adefolarin A. Amu, Zinhle Matsebula, Aubrey Kalungia, Trust Zaranyika, Nyasha Masuka, Janney Wale, Ruaraidh Hill, Amanj Kurdi, Angela Timoney, Stephen Campbell, Johanna C. Meyer
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
BackgroundThere has been an appreciable increase in the number of people in Africa with metabolic syndrome and Type 2 diabetes (T2DM) in recent years as a result of a number of factors. Factors include lifestyle changes, urbanisation, and the growing
Externí odkaz:
https://doaj.org/article/c1ae13958a97493bbdf280dcff5993e8
Publikováno v:
AACE Clinical Case Reports, Vol 1, Iss 1, Pp e79-e 80 (2015)
ABSTRACT: Abbreviations: HbA1c glycated hemoglobin U-500R 500IU/mL regular insulin
Externí odkaz:
https://doaj.org/article/9a3e23258c06468ba8c9836f97e80752
Autor:
Greg Hough, David Segal, Larry A. Distiller, Wayne May, Jacobus van Dyk, Sedeshan Govender, Stanley Landau
Publikováno v:
Journal of Endocrinology and Diabetes. 6:1-5
Autor:
Brian Godman, Debashis Basu, Yogan Pillay, Julius C. Mwita, Godfrey Mutashambara Rwegerera, Bene D. Anand Paramadhas, Celda Tiroyakgosi, Patrick Mbah Okwen, Loveline Lum Niba, Justice Nonvignon, Israel Sefah, Margaret Oluka, Anastasia N. Guantai, Dan Kibuule, Francis Kalemeera, Mwangana Mubita, Joseph Fadare, Olayinka O. Ogunleye, Larry A. Distiller, Enos M. Rampamba, Jeffrey Wing, Debjani Mueller, Abubakr Alfadl, Adefolarin A. Amu, Zinhle Matsebula, Aubrey Kalungia, Trust Zaranyika, Nyasha Masuka, Janney Wale, Ruaraidh Hill, Amanj Kurdi, Angela Timoney, Stephen Campbell, Johanna C. Meyer
Publikováno v:
Frontiers in Pharmacology
FRONTIERS IN PHARMACOLOGY
Frontiers in Pharmacology, Vol 11 (2020)
FRONTIERS IN PHARMACOLOGY
Frontiers in Pharmacology, Vol 11 (2020)
Background: There has been an appreciable increase in the number of people in Africa with metabolic syndrome and Type 2 diabetes (T2DM) in recent years as a result of a number of factors. Factors include lifestyle changes, urbanisation, and the growi
Autor:
Larry A. Distiller
Publikováno v:
Journal of Endocrinology, Metabolism and Diabetes of South Africa; Vol 23, No 3 (2018); 59-63
Continuous glucose monitoring (CGM) is being used increasingly both in patients on insulin pumps (CSII) and more recently in those on multiple injection regimens (MIR). This review lists the CGM devices available in South Africa and explores the lite
Autor:
Abhinav Sharma, Renato D. Lopes, John M. Lachin, Eberhard Standl, Eric D. Peterson, Juliana C.N. Chan, Keith D. Kaufman, Russell S. Scott, Paul W. Armstrong, Larry A. Distiller, Frans Van de Werf, Rury R. Holman, Sana M. Al-Khatib, John B. Buse, Allison Dunning, Jennifer B. Green, Yuliya Lokhnygina
Publikováno v:
Diabetes care. 40(12)
OBJECTIVE We evaluated the specific causes of death and their associated risk factors in a contemporary cohort of patients with type 2 diabetes and atherosclerotic cardiovascular disease (ASCVD). RESEARCH DESIGN AND METHODS We used data from the Tria
Publikováno v:
Integrated Diabetes Care ISBN: 9783319133881
The South African healthcare environment, with its many challenges and resources, provides opportunity for the development of innovative and cost-effective approaches to the management of the increasing burden of diabetes mellitus. In 1994, the Centr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a22caec6b06a64bace5b47c1486ca13
https://doi.org/10.1007/978-3-319-13389-8_6
https://doi.org/10.1007/978-3-319-13389-8_6
Background: In 2014, an innovative blinded continuous glucose monitoring system was introduced with automated ambulatory glucose profile (AGP) reporting. The clinical use and interpretation of this new technology has not previously been described. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e145479d3e61f239afac134a434ede74
https://europepmc.org/articles/PMC5094324/
https://europepmc.org/articles/PMC5094324/
Publikováno v:
Metabolic Syndrome and Related Disorders. 8:539-543
Increasing numbers of patients with type 1 diabetes (T1DM) are developing features of the metabolic syndrome. The additional effect of this on the development of atherosclerosis, as inferred by the carotid artery intima media thickness (IMT), has not
Autor:
Larry A. Distiller
Publikováno v:
Journal of Endocrinology, Metabolism and Diabetes of South Africa. 14:125-128
Results from several randomised controlled trials have demonstrated conclusively that microvascular complications can be reduced in patients with both type 11,2 and type 23–5 diabetes. These trials have indicated that an HbA1c level ≤ 7% is a rea